US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Articles published by Fibrobiologics, Inc.

< Previous 1 2 3 Next >
News headline image
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces 2025 Annual Meeting of Stockholders
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces $25 Million Financing
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Engages Southern Star Research as CRO in Australia
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files 2024 Second Quarter Report
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Set to Join Russell 2000® Index
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Announces 2024 Annual Meeting of Stockholders
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics Files 2024 First Quarter Report
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
News headline image
FibroBiologics to Present at the BIO International Convention 2024
From Fibrobiologics, Inc.
Via GlobeNewswire
Tickers FBLG
< Previous 1 2 3 Next >